CXCR2 and neoplasm: For instance, Yoon et al. demonstrated that anti-mesothelin CAR-NKs with incorporated CXCR2 exhibited enhanced tumour killing and strong infiltration of tumour sites in pancreatic 2D cancer cell co-culture and 3D tumour-mimetic organoid models [76,77].